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Abstract
Objective: The goal of this study is to demonstrate an alternative procedure to perform topical photodynamic
therapy (PDT). Here, we propose the combined use of negative pressure and a 5-Aminolevulinic acid
(5-ALA) cream occlusion to increase protoporphyrin IX (PPIX) formation. Background data: PDT using
topical 5-ALA as a prodrug and precursor of PPIX has been used in the treatment and diagnosis of different
types of cancer and skin diseases. The use of 5-ALA offers many advantages as a localized and non-systemic
application, but it shows limitations in relation to skin penetration. Many authors have discussed the limitations
of 5-ALA penetration through the skin. The skin penetration of 5-ALA can be optimized using mechanical
devices associated with typical PDT procedure. Methods: For this study, 20% 5-ALA cream was applied to a
9 cm2 area of skin, and an occlusive dressing was placed. The PPIX production was collected at the skin surface,
using fluorescence spectroscopy and widefield fluorescence imaging, for 7 h, and after 24 h. Results: We
observed that in the presence of negative pressure therapy, the PPIX production, distribution, and elimination
are greater and faster than in the control group. The PPIX formation was*30% in deeper skin layers, quantified
by fluorescence spectroscopy analysis, and *20% in surface skin layers, quantified by widefield fluorescence
imaging analysis. Conclusions: Negative pressure induction can also help PDT application in the case of
inefficient PPIX production. These results can be useful for optimizing the PDT.
Introduction
Photodynamic therapy (PDT) is a procedure that ex-ploits the consequences originating from localized oxi-
dative damage inflicted by photochemical processes.1 There
are three critical elements required for PDT: a drug that can
be activated by light [a photosensitizer (PS)], light, and ox-
ygen. Light interacting with a PS produces an excited triplet
state, which interacts with ground state oxygen creating
singlet oxygen (102).
1–3 The highly reactive singlet oxygen
promotes oxidative damage in the immediate vicinity of the
subcellular site of a localized PS.3
The tissue response to PDT depends upon adequate tu-
mor oxygenation, as well as sufficient accumulation of a
PS.4 PDT, using 5-Aminolevulinic acid (5-ALA), as a
precursor of protoporphyrin IX (PPIX), has been used in
the treatment and diagnosis of different types of cancer,
skin diseases, and skin aging.1,5 5-ALA is found naturally
in our body, and is converted into PPIX, the immediate
precursor of heme. Because of the feedback mechanism,
the excess exogenous 5-ALA results in intracellular accu-
mulation of PPIX. PPIX is the endogenous PS used in
topical PDT.6
5-ALA can permeate easily into the epidermis of can-
cerous tissue, because of altered metabolism, but not normal
epidermis, thus creating highly selective photosensitivity in
tumor tissue.1 All topical application interference involving
5-ALA during PDT can be summarized accordingly: prob-
lems related to chemical and physicochemical characteris-
tics of 5-ALA, problems with the light system (ideal
fluence), tumor surface characteristics (tumor depth and skin
thickness), adjuvant mechanical techniques used in the
treatment, and increasing the temperature of the skin.7
Therefore, 5-ALA penetration through skin depends upon
the optimization of all these parameters.6–8 Another im-
portant aspect, normally not considered, is the condition of
tissue in relation to its ability to convert 5- ALA in PPIX.
Negative pressure therapy, also known as vacuum ther-
apy, has been used to heal wounds.9,10 The negative pressure
affects the microvascular blood flow by increasing the blood
flow. This alteration in the blood flow occurs because of
modification in the vascular diameter, blood flow velocity,
blood volume, and others things.10,11
The purpose of this work is to show that it is possible to
increase the formation, distribution, and elimination of
PPIX, produced by its precursor 5-ALA through the skin,
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using negative pressure. The possibility of increasing the
amount of PPIX production, decreasing the interval between
the application of 5-ALA cream, and irradiation time, can be
useful to clinical PDT in transdermal applications.
In conclusion, the negative pressure can also help PDT
application in the case of inefficient PPIX production, as it
grows the production and uniformity of PPIX in the skin,
increasing the effectiveness of PDT.
Materials and Methods
Chemicals
The studies were done using 5-Aminolevulinic acid hy-
drochloride (5-ALA) with a 20% concentration, in an oil-
in-water emulsion (O/W) obtained from PDT-PHARMA
(Brazil). The formulation was evenly applied to a circular area
of 9 cm2 with a sterile spatula, using a density of 32mg/cm2.
The area was dressed with an occlusive mask to protect it
from light.
Equipment for negative pressure induction
The vacuum prototype used to stimulate PPIX production
in the skin can be adjusted from 0 to 550mm Hg (negative
pressure), operating in continuous or pulsed mode. This
study was performed using 200mm Hg for 4min, during
which we alternated between continuous mode (5 sec) and
pulsed mode (55 sec). The temperature increases in the skin
were evaluated using an infrared thermometer (ST-600,
Incoterm, Sa˜o Paulo) at 1 h intervals.
Volunteers: inclusion and exclusion criteria
The protocol used in this study followed the procedures
establish by Human Research Ethics Committee of Brazil.
Written informed consent was obtained from all participants.
Ten women patients,*25 years of age with a clinical diag-
nosis of normal skin, were recruited for this clinical study. All
patients had Fitzpatrick skin types II (50%) or III (50%). To be
considered eligible, a patient had to be free of skin disorders
on both arms. Patients with lesions in the target area or with
porphyria were excluded. Additional exclusion criteria in-
cluded pregnancy, lactation, an allergy to 5-ALA, male gen-
der, and being < 20 or > 35 years of age.
Treatment procedure
The study was randomized with two treatment groups.
The first treatment group was treated with 20% 5-ALA
cream and a vacuum device for negative pressure induction
(NP-G). For the second treatment group, the control group
(CG), treatment was performed on the volunteers’ other
arm. Autofluorescence of the skin was used as the control
for each group. Comparisons were made for each treatment
group and between both treatments.
First, the 5-ALA cream and the vacuum device were
applied for 4min. Following this, the fluorescence was
measured at the skin surface using a spectrometer, and
pictures of the area were taken using widefield fluorescence
imaging equipment, as previously described. At the end of
the fluorescence analysis, 5-ALA cream was reapplied to
the treatment area and covered with an occlusive dressing.
The same procedure was performed on the other arm without
the use of the vacuum device.
Fluorescence spectroscopy
Fluorescence collection was done using a system com-
posed of a doubled Nd:YAG laser emitting at 532 nm, and a
spectrometer, collecting fluorescence in the range of 400–
1000 nm as previously described by us.12 For fluorescence
spectrum analysis, we collected the fluorescence spectrum in
contact with the tissue at five points in the 9 cm2 circular
area. At each point, 20 fluorescence and autofluorescence
measurements were performed. The evaluations from
spectra analyses were performed using the maximum value
of the fluorescence spectrum (at 633 nm) from PPIX for 7 h.
The spectrum evaluations were performed using Matlab 12
platform (The MathWorks, USA).
Widefield fluorescence imaging
For this study, commercial equipment called ‘‘Evince’’
was used (MM Optics, Brazil), which is composed of a
lighting device based on LEDs, emitting*400 and 450 nm,
a high-pass filter, dichroic mirrors, a band pass filter, and a
CCD camera for image acquisition.
The widefield fluorescence imaging was collected at the
skin surface at each hour, from 1 to 7 h, and in 24 h. The
analysis was performed by collecting five images of the
treatment area each hour and evaluating the pixel count.
The variation in the number of red pixels was*5–8%. The
image processing was performed on a routine written in
MATLAB, using a matrix that separates the RGB pixels,
and counts only the red pixels of all intensities (from the
lightest to the darkest).
The statistical analyses for both fluorescence evaluations
were performed using principal components analysis (PCA),
as well as the ANOVA test (0.05%). The PCA have been
used as a multidimensional statistical tool to evaluated dif-
ferences between the data.6,13,14 The PCA was performed on
the whole fluorescence spectrum. An algorithm was con-
structed for each spectrum processing method and applied
for the data, using Matlab 12 platform.15 The PCA is used
in most cases to investigate the dependence and connections
among variables, reducing and simplifying data, and clas-
sifying them into groups.16 This technique has been applied
in fluorescence spectroscopy evaluations even as in the
Raman spectroscopy.17
Results
A typical fluorescence spectrum for PPIX production in
the target tissue using topical application of 20% 5-ALA
cream is presented in Fig. 1. The presence of PPIX is
identified by two strong peaks at 633 and 700 nm.18 In
FIG. 1. Fluorescence spectrum from protoporphyrin IX
(PPIX) formation kinetics in human volunteers.
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addition, use of the vacuum prototype on a volunteer is
shown in Fig. 2.
There are differences in the skin layers of young and old
people, as the skin thickness decreases with age.19 The
natural aging process of skin results as a biological change
that occurs because of a decrease in the dermal–epidermal
interface.13 The transdermal permeation of drugs varies
according to the age of skin, skin type, the body region, and
the environmental condition of the skin.20 In this study, skin
aging differences related to drug permeation through the
skin were not evaluated. To minimize the variability, we
preferred to limit the range of volunteers’ ages.
Considering the ages of our volunteers, the analyses by
widefield fluorescence, using LED in 408 nm, brings us in-
formation about the amount of PPIX produced at superficial
skin layers at a depth*0.1mm or 100 lm (stratum corneum
and superficial epidermis). On the other hand, the fluores-
cence spectroscopic analyses, using laser in 532 nm, shows
us information about deeper skin layers at depth *0.4mm
or 400lm (epidermis and epidermis–dermis junctions).
In Fig. 3, we can see the PPIX formation kinetics by
fluorescence spectroscopy analyses up to 7 h of treatment for
all volunteers. The PPIX rate formation and overall amount
formed is greater in the treatment group than in the control
group. The rate formation of PPIX reaches the maximum
values at 6 h of treatment, at which there were 30% differ-
ences between treatment groups. After this time, the PPIX
elimination from deeper skin layers increases and overall
elimination begins.
Simulating the PPIX elimination curve in Fig. 3, complete
elimination, in agreement with our results, occurs*12h and
14 h in the treatment and control group, respectively (results
not shown here). These results suggest that elimination from
deeper tissue can occur faster in the NP-G treatment group
than in the CG.
In Fig. 4, we can see the PPIX formation, distribution, and
elimination kinetics through qualitative evaluations, using
FIG. 2. Applying vacuum prototype to volunteer’s arm.
FIG. 3. Protoporphyrin IX (PPIX) formation kinetics by
fluorescence spectroscopy analysis. Fluorescence intensity
corresponds to the greater amplitude of PPIX band at
633 nm for each time until 7 h into the experiment. The
pharmacokinetics from PPIX were obtained through in-
creases of the band at 633 nm. Error bars are standard de-
viations obtained from measurement of 10 independent
volunteers.
FIG. 4. Widefield fluorescence imaging from a volunteer during study time (24 h). Treatment group (right arm) and
control group (left arm).
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widefield fluorescence imaging 24 h after treatment in one
volunteer. The PPIX formation is faster and greater in the
NP-G than in the CG. Also, the PPIX distribution is more
homogeneous in the NP-G than in the CG. We believe that
this occurs as a result of stimulating the net of microvessels,
allowing for a more uniform production and distribution of
PPIX within the considered area.
As we can see in Fig. 4, the CG induces PPIX formation in
lower quantities than the NP-G, and reaches a higher amount
of PPIX formation in the interval between 7 and 24h. These
data suggests that the use of negative pressure decreases the
photosensitivity of skin. Another aspect to emphasize is that
the elimination from skin surface is faster in the NP-G than in
the CG after 24 h. The complete elimination of PPIX occurs
after 48 h (results not shown here). This can be beneficial
because PDT can be spread over 2 days.
The PPIX formation kinetics by quantitative analyses
using widefield fluorescence imaging 24 h after treatment
for all volunteers is shown in Fig. 5.
In the superficial layers, PPIX formation is faster and
greater in the NP-G than in the CG, and reaches a maximum
value after 6 h of treatment, and then remains constant.
The results obtained by widefield fluorescence imaging in
Fig. 5 showed that the differences between treatment groups
is *20% at 6 h, which is comparable to our previous
measurement (Fig. 3).
As we can see from the results, negative pressure induc-
tion increases the blood flow and the temperature, increasing
the PPIX formation levels of the skin. From infrared ther-
mometer evaluations, the temperature increases 2 in the
presence of negative pressure induction. These results are in
agreement with the literature, and are connected to increas-
ing drug permeation through the skin.18,21
In Fig. 6A it is possible to see that the autofluorescence of
tissue decreases with negative pressure induction and
by PCA evaluations, and in Figure 6B we prove that this
change exists and is larger.
Figures 7 and 8 present the statistical differences be-
tween both treatment evaluations calculated by PCA for all
volunteers.
Discussion
Knowing the limitations of topical PDT using ALA and
its derivatives, the negative pressure induction will be useful
optimizing the penetration of ALA through the skin, even as
the production of PPIX at different skin layers.
This happens because of an increase of blood flow rich in
hemoglobin, a protein that absorbs the same range of laser
wavelengths as those used to collect the fluorescence mea-
sures (see the Materials and Methods section). The negative
pressure induction affects the microvascular blood flow, and
can be useful in cancer treatment, optimizing the use of
topical ALA in clinical PDT.10,11
In our study, we have used normal skin as the model. It is
important, however, to point out that in skin cancer tissue, the
overall vascular structure is very different. The relatively poor
FIG. 5. Pharmacokinetics of protoporphyrin IX (PPIX)
through the skin by widefield fluorescence imaging analy-
ses. Fluorescence intensity corresponds to the number of red
pixels, from PPIX, in the image. Error bars are standard
deviations obtained from measurement of 10 independent
volunteers.
FIG. 6. (A) Autofluorescence spectrum of protoporphyrin IX (PPIX) formation kinetics in human volunteers, using a laser
in 408 and 532 nm, before and after negative pressure induction (suction). (B) Principal components analysis (PCA) using
fluorescence spectroscopy analyses. The PCA of autofluorescence evaluations was performed before and after suction.
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microvascularization of the tumor area may result in a much
more accentuated effect when negative pressure is applied.22
This study suggested that the production, distribution, and
elimination of PPIX are faster in the NP-G than in the CG.
The results produced here demonstrated the potential clini-
cal application of negative pressure in order to optimize
topical 5-ALA-PDT.
Widefield fluorescence imaging showed a greater, faster,
and more homogenous increase in PPIX production at the
skin surface in the NP-G than in the CG. The differences
found were *20% and demonstrate that widefield fluores-
cence imaging is a practical technique, which can be readily
applied in clinical PDT. This technique has been applied
widely in our laboratory in tumor tissue diagnosis and in
PDT monitoring the PPIX production, elimination, and
distribution at skin.23–25
The fluorescence spectroscopic technique has also been
used as a diagnostic tool evaluating the spectral modifica-
tions on tissue, and can be applied in the diagnosis of tumor
tissues and in liver transplantation, as well as in the evalu-
ation of tissue modifications after death.15,26,27
In agreement with our results, the maximum amount of
PPIX production, evaluated by fluorescence spectroscopic
and widefield fluorescence imaging analyses, is faster and
greater in the deeper layers (30%) than at the surface (20%)
6 h after the initiation of the study. Six h after the applica-
tion of 20% 5-ALA cream, PPIX formation in deeper layers
decreased, but remained constant in the surface layer of the
NP-G, and increased for 24 h in the CG, remaining constant
after that.
The differences found using normal skin, 30% in spec-
troscopy evaluations and 20% in widefield fluorescence,
were statistically significant in PCA analysis. Considering
the data, we hypothesize that the differences will be *50–
60% in abnormal skin. This study has the ability to develop
new procedures to improve topical PDT.
After 48 h (results not shown here), the complete elimi-
nation of PPIX, from skin surface, occurs faster in the NP-G
than in the CG.
The fast elimination of the PS in PDT is an interesting
advantage, decreasing the sensitivity of the skin, thereby
minimizing this undesirable effect in PDT treatment of
cancer. Certainly this procedure can be faster, amplified,
when skin cancer is possible.
Conclusions
In this study, we have used normal skin as the model to
evaluate the benefits of negative pressure induction in top-
ical PDT using 5-ALA. The next step in this research will be
the application of negative pressure to basal-cell carcinoma
(BCC) skin cancer.
The differences found using normal skin, 30% in spec-
troscopy evaluations, and 20% in widefield fluorescence, were
statistically significant in PCA. Considering these data, we
hypothesize that the differences will be *50–60% in abnor-
mal skin. This study has the ability to develop new procedures
to improve the topical application of 5-ALA in PDT.
In summary, our study demonstrates the high potential of
negative pressure in clinical applications, optimizing PDT.
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